In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing

被引:18
作者
Hansen, G. [2 ,3 ]
Swanzy, S. [1 ]
Gupta, R. [1 ]
Cookson, B. [1 ]
Limaye, A. P. [1 ]
机构
[1] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] Hennepin Cty Med Ctr, Dept Pathol, Minneapolis, MN 55415 USA
关键词
D O I
10.1007/s10096-007-0413-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fluoroquinolones have several properties that make them potentially attractive candidates for the treatment of Nocardia infections, but information regarding their in vitro activity is limited. Minimum inhibitory concentrations (MIC) of five fluoroquinolones and other antimicrobials were determined by the reference broth dilution and E-test methods for 33 consecutive clinical isolates of Nocardia speciated by 16S rRNA gene sequences. The isolates included: Nocardia cyriacigeorgica (n=6), N. nova (n=8), N. farcinica (n=8), N. brasiliensis (n=3), N. asteroides (n=4), and N. veterana (n=4). MIC50/MIC90 results for ciprofloxacin, gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin by broth dilution were 32/32, 2/4, 1/4, 32/32, and 2/2 mu g/ml, respectively. The MICs by broth dilution and E-test were within a two-fold doubling dilution for 94%, 97%, 97%, 100%, and 100% of isolates for ciprofloxacin, gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin, respectively. For ciprofloxacin, the E-test results showed either complete categorical agreement or minor error compared to the reference broth dilution method for 97% (32/33) of the isolates. For other fluoroquinolones, using Streptococcus pneumoniae breakpoints, 94% (124/132) of MIC results by E-test showed either complete agreement or minor error compared to the reference broth dilution method. Fluoroquinolones show variable in vitro activity against clinical isolates of Nocardia spp., and MICs determined by the E-test show reasonable agreement with those determined by the reference broth dilution method.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 17 条
[1]   Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex [J].
Ambaye, A ;
Kohner, PC ;
Wollan, PC ;
Roberts, KL ;
Roberts, GD ;
Cockerill, FR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) :847-852
[2]  
[Anonymous], 2007, MS100S17 CLSI
[3]   COMPARATIVE-EVALUATION OF THE E-TEST FOR SUSCEPTIBILITY TESTING OF NOCARDIA SPECIES [J].
BIEHLE, JR ;
CAVALIERI, SJ ;
SAUBOLLE, MA ;
GETSINGER, LJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (02) :101-110
[4]   Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy [J].
Brown-Elliott, BA ;
Brown, JM ;
Conville, PS ;
Wallace, RJ .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (02) :259-+
[5]  
CLSI, 2003, SUSC TEST MYC NOC OT
[6]   Disseminated nocardiosis caused by Nocardia abscessus in an HIV-infected patient:: first reported case [J].
Diego, C ;
Ambrosioni, JC ;
Abe, G ;
Fernando, B ;
Tomás, O ;
Ricardo, N ;
Jorge, B .
AIDS, 2005, 19 (12) :1330-1331
[7]   Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae [J].
Fukuda, H ;
Kishii, R ;
Takei, M ;
Hosaka, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1649-1653
[8]   Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest [J].
Glupczynski, Y. ;
Berhin, C. ;
Janssens, M. ;
Wauters, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) :905-912
[9]  
KIM JM, 1991, REV INFECT DIS, V13, P624
[10]   Gatifloxacin activity against quinolone-resistant gyrase: Allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group [J].
Lu, T ;
Zhao, XL ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2969-2974